Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disulfide bridges are covalent linkages between cysteine residues in mucin polymers that are critical for the assembly, stability, and function of mucus gels. They drive mucin dimerization and higher-order polymerization, forming a stable network essential for the viscoelastic properties and barrier function of mucus on epithelial surfaces. Defects in disulfide bridge formation can compromise mucus integrity and contribute to diseases such as COPD and cystic fibrosis.
Disrupting or modulating disulfide bond formation to alter mucus properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disulfide Bridges of Mucin Polymers.